Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-22 9:11:2 am | Humacyte, Inc. (HUMA) Q4 2023 Earnings Call Transcript | SeekingAlpha |
| 2024-03-22 4:0:0 am | Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update | GlobeNewswire |
| 2024-03-18 5:0:0 am | Humacyte to Present 2023 Fourth Quarter and Year-End Financial Results and Provide Corporate Update on March 22, 2024 | GlobeNewswire |
| 2024-03-01 6:16:0 am | Humacyte, Inc. to Present at the TD Cowen 44th Annual Health Care Conference | GlobeNewswire |
| 2024-02-29 6:18:0 pm | Humacyte, Inc. Announces Pricing of $40.2 Million Public Offering of Common Stock | GlobeNewswire |
| 2024-02-29 1:1:0 pm | Humacyte, Inc. Announces Proposed Public Offering of Common Stock | GlobeNewswire |
| 2024-02-09 5:0:0 am | Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information